Orca Capital AG 13D and 13G filings for Lixte Biotechnology Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-18 4:15 pm Sale | 2025-02-14 | 13G | Lixte Biotechnology Holdings, Inc. LIXT | Orca Capital AG | 120,012 4.500% | -97,380 (-44.79%) | Filing |
| 2025-02-13 4:48 pm Purchase | 2025-02-11 | 13G | Lixte Biotechnology Holdings, Inc. LIXT | Orca Capital AG | 217,392 8.100% | 217,392 (New Position) | Filing |